145202-66-0 Rizatriptan benzoate AKSci J99625
 
 
Loading Please Wait...
  J99625    
Rizatriptan benzoate
, 95%
 
MK-462
Maxalt
N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine benzoate salt




IDENTITY
CAS Number:145202-66-0
MDL Number:MFCD00866224
MF:C22H25N5O2
MW:391.47
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:95%
Physical Form (at 20°C):Solid
Melting Point:175-184°C
Long-Term Storage:Store long-term in a cool, dry place
DOT/IATA TRANSPORT INFORMATION
Not hazardous material

BIOLOGICAL INFO
Solubility:DMSO: 20mg/mL; H2O: 46mg/mL; EtOH: <1mg/mL
Application(s):5-HT1 agonist
Form:Benzoate salt

REVIEW

 A serotonin 5-HT1 agonist triptan drug for the treatment of migraine headaches.

REFERENCES
[1]Ho TW, Pearlman E, Lewis D, Hämäläinen M, Connor K, Michelson D, Zhang Y, Assaid C, Mozley LH, Strickler N, Bachman R, Mahoney E, Lines C, Hewitt DJ; Rizatriptan Protocol 082 Pediatric Migraine Study Group (2012). Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia. 32(10):750-65. PMID 22711898.
[2] Müller T, Lohse L (2011). Efficacy of parecoxib, sumatriptan, and rizatriptan in the treatment of acute migraine attacks. Clin Neuropharmacol. 34(6):206-9. PMID 21996647.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Danger

Hazard Statements
H360

Precautionary Statements
P201; P202; P281; P308+P313; P405; P501


Current as of September 29, 2022


Download SDS Request COA

⚠️
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information.


CATEGORIES

 APIs and Bioactives > Serotonin Agonists


PubChem